{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T13:53:11Z","timestamp":1776001991812,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1008375","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000}}],"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"USA Department of Energy","award":["89233218CNA000001"],"award-info":[{"award-number":["89233218CNA000001"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI078881"],"award-info":[{"award-number":["R01-AI078881"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-OD011095"],"award-info":[{"award-number":["R01-OD011095"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["HR0011-17-C-0067"],"award-info":[{"award-number":["HR0011-17-C-0067"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","award":["IAA3025"],"award-info":[{"award-number":["IAA3025"]}],"id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Mathematical modelling has successfully been used to provide quantitative descriptions of many viral infections, but for the Ebola virus, which requires biosafety level 4 facilities for experimentation, modelling can play a crucial role. Ebola virus modelling efforts have primarily focused on<jats:italic>in vivo<\/jats:italic>virus kinetics, e.g., in animal models, to aid the development of antivirals and vaccines. But, thus far, these studies have not yielded a detailed specification of the infection cycle, which could provide a foundational description of the virus kinetics and thus a deeper understanding of their clinical manifestation. Here, we obtain a diverse experimental data set of the Ebola virus infection<jats:italic>in vitro<\/jats:italic>, and then make use of Bayesian inference methods to fully identify parameters in a mathematical model of the infection. Our results provide insights into the distribution of time an infected cell spends in the eclipse phase (the period between infection and the start of virus production), as well as the rate at which infectious virions lose infectivity. We suggest how these results can be used in future models to describe co-infection with defective interfering particles, which are an emerging alternative therapeutic.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1008375","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T18:45:10Z","timestamp":1604342710000},"page":"e1008375","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Quantification of Ebola virus replication kinetics in vitro"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6069-2633","authenticated-orcid":true,"given":"Laura E.","family":"Liao","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1372-3254","authenticated-orcid":true,"given":"Jonathan","family":"Carruthers","sequence":"additional","affiliation":[]},{"given":"Sophie J.","family":"Smither","sequence":"additional","affiliation":[]},{"name":"CL4 Virology Team","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9286-2991","authenticated-orcid":true,"given":"Simon A.","family":"Weller","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0322-5972","authenticated-orcid":true,"given":"Diane","family":"Williamson","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0142-9162","authenticated-orcid":true,"given":"Thomas R.","family":"Laws","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5654-5662","authenticated-orcid":true,"given":"Isabel","family":"Garc\u00eda-Dorival","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6582-0275","authenticated-orcid":true,"given":"Julian","family":"Hiscox","sequence":"additional","affiliation":[]},{"given":"Benjamin P.","family":"Holder","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0599-0069","authenticated-orcid":true,"given":"Catherine A. A.","family":"Beauchemin","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2455-0002","authenticated-orcid":true,"given":"Alan S.","family":"Perelson","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3833-8595","authenticated-orcid":true,"given":"Mart\u00edn","family":"L\u00f3pez-Garc\u00eda","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7966-5571","authenticated-orcid":true,"given":"Grant","family":"Lythe","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9035-2039","authenticated-orcid":true,"given":"John N.","family":"Barr","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9828-6737","authenticated-orcid":true,"given":"Carmen","family":"Molina-Par\u00eds","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"issue":"9768","key":"pcbi.1008375.ref001","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0140-6736(10)60667-8","article-title":"Ebola haemorrhagic fever","volume":"377","author":"H Feldmann","year":"2011","journal-title":"Lancet"},{"key":"pcbi.1008375.ref002","article-title":"Make Ebola a thing of the past: First vaccine against deadly virus approved","author":"E Callaway","year":"2019","journal-title":"Nature"},{"issue":"9","key":"pcbi.1008375.ref003","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(17)30234-7","article-title":"Insights from clinical research completed during the west Africa Ebola virus disease epidemic","volume":"17","author":"A Rojek","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"pcbi.1008375.ref004","first-page":"171","article-title":"First newborn baby to receive experimental therapies survives Ebola virus disease","volume":"215","author":"J D\u00f6rnemann","year":"2017","journal-title":"J Infect Dis"},{"issue":"3","key":"pcbi.1008375.ref005","doi-asserted-by":"crossref","first-page":"e1001967","DOI":"10.1371\/journal.pmed.1001967","article-title":"Experimental treatment with favipiravir for Ebola virus disease (the JIKI trial): A historically controlled, single-arm proof-of-concept trial in Guinea","volume":"13","author":"D Sissoko","year":"2016","journal-title":"PLoS Med"},{"issue":"6","key":"pcbi.1008375.ref006","doi-asserted-by":"crossref","first-page":"e0005545","DOI":"10.1371\/journal.pntd.0005545","article-title":"Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A cast study in Guinea, West Africa","volume":"11","author":"SC Perez","year":"2017","journal-title":"Plos Negl Trop Dis"},{"issue":"15","key":"pcbi.1008375.ref007","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1604330","article-title":"A randomized, controlled trial of ZMapp for Ebola virus infection","volume":"375","author":"TPIW Group","year":"2016","journal-title":"N Engl J Med"},{"issue":"7721","key":"pcbi.1008375.ref008","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/d41586-018-06132-7","article-title":"Experimental Ebola drugs face tough test in war zone","volume":"561","author":"A Maxmen","year":"2018","journal-title":"Nature"},{"issue":"5255","key":"pcbi.1008375.ref009","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"issue":"15","key":"pcbi.1008375.ref010","doi-asserted-by":"crossref","first-page":"7590","DOI":"10.1128\/JVI.01623-05","article-title":"Kinetics of influenza A virus infection in humans","volume":"80","author":"P Baccam","year":"2006","journal-title":"J Virol"},{"issue":"33","key":"pcbi.1008375.ref011","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.1704011114","article-title":"Zika plasma viral dynamics in nonhuman primates provides insights into early infection and antiviral strategies","volume":"114","author":"K Best","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"pcbi.1008375.ref012","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.antiviral.2015.08.015","article-title":"Ebola virus dynamics in mice treated with favipiravir","volume":"123","author":"V Madelain","year":"2015","journal-title":"Antiviral Res"},{"issue":"3","key":"pcbi.1008375.ref013","doi-asserted-by":"crossref","first-page":"e1002535","DOI":"10.1371\/journal.pmed.1002535","article-title":"Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgous macaques","volume":"15","author":"J Guedj","year":"2018","journal-title":"PLoS Med"},{"issue":"1","key":"pcbi.1008375.ref014","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1038\/s41467-018-06215-z","article-title":"Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies","volume":"9","author":"V Madelain","year":"2018","journal-title":"Nat Commun"},{"key":"pcbi.1008375.ref015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.antiviral.2016.10.004","article-title":"Modelling Ebola virus dynamics: Implications for therapy","volume":"135","author":"A Martyushev","year":"2016","journal-title":"Antiviral Res"},{"issue":"1","key":"pcbi.1008375.ref016","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1016\/S2214-109X(16)30243-1","article-title":"Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study","volume":"5","author":"D Sissoko","year":"2017","journal-title":"The Lancet Glob Health"},{"key":"pcbi.1008375.ref017","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.coisb.2018.08.009","article-title":"Progress and trends in mathematical modelling of influenza A virus infections","volume":"12","author":"A Handel","year":"2018","journal-title":"Curr Opin Syst Biol"},{"issue":"1","key":"pcbi.1008375.ref018","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/bit.20363","article-title":"Mathematical model of influenza A virus production in large-scale microcarrier culture","volume":"90","author":"L M\u00f6hler","year":"2005","journal-title":"Biotechnol Bioeng"},{"key":"pcbi.1008375.ref019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1742-4690-9-18","article-title":"Quantification system for the viral dynamics of a highly pathogenic simian\/human immunodeficiency virus based on an in vitro experiment and a mathematical model","volume":"9","author":"S Iwami","year":"2012","journal-title":"Retrovirology"},{"key":"pcbi.1008375.ref020","doi-asserted-by":"crossref","first-page":"42765","DOI":"10.1038\/srep42765","article-title":"Duration of SHIV production by infected cells is not exponentially distributed: Implications for estimates of infection parameters and antiviral efficacy","volume":"7","author":"CAA Beauchemin","year":"2017","journal-title":"Sci Rep"},{"key":"pcbi.1008375.ref021","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.08150","article-title":"Cell-to-cell infection by HIV contributes over half of virus infection","volume":"4","author":"S Iwami","year":"2015","journal-title":"Elife"},{"issue":"4","key":"pcbi.1008375.ref022","doi-asserted-by":"crossref","first-page":"e0214708","DOI":"10.1371\/journal.pone.0214708","article-title":"Uncovering critical properties of the human respiratory syncytial virus by combining in vitro assays and in silico analyses","volume":"14","author":"CAA Beauchemin","year":"2019","journal-title":"PLoS ONE"},{"issue":"2","key":"pcbi.1008375.ref023","doi-asserted-by":"crossref","first-page":"e0192645","DOI":"10.1371\/journal.pone.0192645","article-title":"A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time","volume":"13","author":"G Gonz\u00e0lez-Parra","year":"2018","journal-title":"PLoS ONE"},{"issue":"1","key":"pcbi.1008375.ref024","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1128\/JVI.01453-12","article-title":"Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigation","volume":"87","author":"M Fukuhara","year":"2013","journal-title":"J Virol"},{"key":"pcbi.1008375.ref025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.virusres.2017.09.023","article-title":"Quantifying rotavirus kinetics in the REH tumor cell line using in vitro data","volume":"244","author":"G Gonz\u00e0lez-Parra","year":"2018","journal-title":"Virus Res"},{"key":"pcbi.1008375.ref026","volume-title":"Mathematical modeling identifies the role of adaptive immunity as a key controller of respiratory syncytial virus (RSV) titer in cotton rats","author":"D Wethington","year":"2018"},{"key":"pcbi.1008375.ref027","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3389\/fmicb.2012.00319","article-title":"Identifying viral parameters from in vitro cell cultures","volume":"3","author":"S Iwami","year":"2012","journal-title":"Front Microbiol"},{"issue":"19","key":"pcbi.1008375.ref028","doi-asserted-by":"crossref","first-page":"10651","DOI":"10.1128\/JVI.07244-11","article-title":"The H275Y neuraminidase mutation of the pandemic A\/H1N1 virus lengthens the eclipse phase and reduces viral output of infected cells, potentially compromising fitness in ferrets","volume":"86","author":"LT Pinilla","year":"2012","journal-title":"J Virol"},{"key":"pcbi.1008375.ref029","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1742-4690-9-89","article-title":"Impact of immune escape mutations on HIV-1 fitness in the context of the cognate transmitted\/founder genome","volume":"9","author":"H Song","year":"2012","journal-title":"Retrovirology"},{"issue":"5","key":"pcbi.1008375.ref030","doi-asserted-by":"crossref","first-page":"e0126115","DOI":"10.1371\/journal.pone.0126115","article-title":"Impact of the H275Y and I223V mutations in the neuraminidase of the 2009 pandemic influenza virus in vitro and evaluating experimental reproducibility","volume":"10","author":"EG Paradis","year":"2015","journal-title":"PLoS ONE"},{"key":"pcbi.1008375.ref031","doi-asserted-by":"crossref","first-page":"24154","DOI":"10.1038\/srep24154","article-title":"Avian influenza viruses that cause highly virulent infections in humans exhibit distinct replicative properties in contrast to human H1N1 viruses","volume":"6","author":"PF Simon","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"pcbi.1008375.ref032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12976-017-0055-8","article-title":"A highly pathogenic simian\/human immunodeficiency virus effectively produces infectious virions compared with a less pathogenic virus in cell culture","volume":"14","author":"S Iwanami","year":"2017","journal-title":"Theor Biol Med Model"},{"key":"pcbi.1008375.ref033","doi-asserted-by":"crossref","first-page":"11761","DOI":"10.1038\/srep11761","article-title":"Quantifying the antiviral effect of IFN on HIV-1 replication in cell culture","volume":"5","author":"H Ikeda","year":"2015","journal-title":"Sci Rep"},{"key":"pcbi.1008375.ref034","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fmicb.2015.00257","article-title":"Ebola virus infection modeling and identifiability problems","volume":"6","author":"VK Nguyen","year":"2015","journal-title":"Front Microbiol"},{"issue":"Suppl 1","key":"pcbi.1008375.ref035","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1471-2458-11-S1-S10","article-title":"Exploring the effect of biological delays in kinetic models of influenza within a host or cell culture","volume":"11","author":"BP Holder","year":"2011","journal-title":"BMC Public Health"},{"key":"pcbi.1008375.ref036","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-1-4939-7116-9_9","volume-title":"Ebolaviruses","author":"N Biedenkopf","year":"2017"},{"issue":"2","key":"pcbi.1008375.ref037","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/135965350400900216","article-title":"Estimates of intracellular delay and average drug efficacy from viral load data of HIV-infected individuals under antiretroviral therapy","volume":"9","author":"NM Dixit","year":"2004","journal-title":"Antivir Ther"},{"issue":"7","key":"pcbi.1008375.ref038","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.4049\/jimmunol.174.7.4198","article-title":"CD8-mediated protection against Ebola virus infection is perforin dependent","volume":"174","author":"M Gupta","year":"2005","journal-title":"The Journal of Immunology"},{"key":"pcbi.1008375.ref039","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.vaccine.2009.02.027","article-title":"Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling","volume":"27","author":"J Schulze-Horsel","year":"2009","journal-title":"Vaccine"},{"issue":"1","key":"pcbi.1008375.ref040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/v12010106","article-title":"Modeling challenges of Ebola virus\u2013host dynamics during infection and treatment","volume":"12","author":"DS Chertow","year":"2020","journal-title":"Viruses"},{"issue":"7","key":"pcbi.1008375.ref041","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.celrep.2016.01.049","article-title":"Differential regulation of interferon responses by Ebola and Marburg virus VP35 proteins","volume":"14","author":"MR Edwards","year":"2016","journal-title":"Cell reports"},{"issue":"3","key":"pcbi.1008375.ref042","doi-asserted-by":"crossref","first-page":"e0194880","DOI":"10.1371\/journal.pone.0194880","article-title":"Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugs","volume":"13","author":"E Postnikova","year":"2018","journal-title":"PLoS ONE"},{"issue":"5","key":"pcbi.1008375.ref043","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1586\/erv.09.19","article-title":"Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines","volume":"8","author":"NP Barrett","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"pcbi.1008375.ref044","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1080\/14760584.2017.1357471","article-title":"Vero cell technology for rapid development of inactivated whole virus vaccines for emerging viral diseases","volume":"16","author":"NP Barrett","year":"2017","journal-title":"Expert Rev Vaccines"},{"issue":"46","key":"pcbi.1008375.ref045","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2009.06.020","article-title":"Suspension-Vero cell cultures as a platform for viral vaccine production","volume":"27","author":"C Paillet","year":"2009","journal-title":"Vaccine"},{"issue":"10","key":"pcbi.1008375.ref046","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1073\/pnas.1203110110","article-title":"Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life","volume":"110","author":"J Guedj","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"pcbi.1008375.ref047","doi-asserted-by":"crossref","first-page":"e1003372","DOI":"10.1371\/journal.pcbi.1003372","article-title":"Multiscale modeling of influenza A virus infection supports the development of direct-acting antivirals","volume":"9","author":"FS Heldt","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"pcbi.1008375.ref048","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fmicb.2018.00601","article-title":"A new age-structured multiscale model of the hepatitis C virus life-cycle during infection and therapy with direct-acting antiviral agents","volume":"9","author":"B de M Quintela","year":"2018","journal-title":"Front Microbiol"},{"key":"pcbi.1008375.ref049","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.3389\/fmicb.2018.01546","article-title":"Mathematical analysis of viral replication dynamics and antiviral treatment strategies: From basic models to age-based multi-scale modeling","volume":"9","author":"C Zitzmann","year":"2018","journal-title":"Front Microbiol"},{"key":"pcbi.1008375.ref050","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.coviro.2018.07.014","article-title":"The defective component of viral populations","volume":"33","author":"VV Rezelj","year":"2018","journal-title":"Curr Opin Virol"},{"issue":"1","key":"pcbi.1008375.ref051","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/viro.1999.9915","article-title":"Ebola virus defective interfering particles and persistent infection","volume":"262","author":"P Calain","year":"1999","journal-title":"Virology"},{"issue":"6","key":"pcbi.1008375.ref052","first-page":"e01178","article-title":"Reidentification of Ebola virus E718 and ME as Ebola virus\/H.sapiens-tc\/COD\/1976\/Yambuku-Ecran","volume":"2","author":"JH Kuhn","year":"2014","journal-title":"Genome Announc"},{"issue":"2","key":"pcbi.1008375.ref053","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jviromet.2013.05.015","article-title":"Comparison of the plaque assay and 50% tissue culture infectious dose assay as methods for measuring filovirus infectivity","volume":"193","author":"SJ Smither","year":"2013","journal-title":"J Virol Methods"},{"issue":"3","key":"pcbi.1008375.ref054","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","article-title":"A simple method of estimating fifty per cent endpoints","volume":"27","author":"LJ Reed","year":"1938","journal-title":"Am J Epidemiol"},{"key":"pcbi.1008375.ref055","unstructured":"Beauchemin CAA. phymcmc: A convenient wrapper for emcee; 2019. https:\/\/github.com\/cbeauc\/phymcmc."},{"issue":"925","key":"pcbi.1008375.ref056","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1086\/670067","article-title":"emcee: The MCMC hammer","volume":"125","author":"D Foreman-Mackey","year":"2013","journal-title":"Publ Astron Soc Pac"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1008375","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,26]],"date-time":"2022-11-26T06:53:29Z","timestamp":1669445609000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1008375"}},"subtitle":[],"editor":[{"given":"Jennifer A.","family":"Flegg","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":56,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,11,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1008375","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1008375","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]}}}